Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis

[1]  M. Sá,et al.  Cognitive Dysfunction in Multiple Sclerosis , 2012, Front. Neur..

[2]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[3]  David H. Miller,et al.  Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial , 2010, The Lancet Neurology.

[4]  M. Buttmann.  Treating multiple sclerosis with monoclonal antibodies: a 2010 update , 2010, Expert review of neurotherapeutics.

[5]  Klaus-Armin Nave,et al.  Myelination and the trophic support of long axons , 2010, Nature Reviews Neuroscience.

[6]  D. Clifford,et al.  Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases , 2010, The Lancet Neurology.

[7]  W. Brück,et al.  Substantial early, but nonprogressive neuronal loss in multiple sclerosis (ms) spinal cord , 2009, Annals of neurology.

[8]  P. Calabresi,et al.  Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double‐blind placebo‐controlled multicenter trial , 2009, Annals of neurology.

[9]  H. Steinbusch,et al.  Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis , 2009, Annals of neurology.

[10]  Peter K. Stys,et al.  Gray matter pathology in (chronic) MS: Modern views on an early observation , 2009, Journal of the Neurological Sciences.

[11]  J. Bennett,et al.  Update on Inflammation, Neurodegeneration, and Immunoregulation in Multiple Sclerosis: Therapeutic Implications , 2009, Clinical neuropharmacology.

[12]  Richard Nicholas,et al.  Substantial Archaeocortical Atrophy and Neuronal Loss in Multiple Sclerosis , 2009, Brain pathology.

[13]  Peter K Stys,et al.  Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis , 2009, The Lancet Neurology.

[14]  H. Weiner,et al.  The challenge of multiple sclerosis: How do we cure a chronic heterogeneous disease? , 2009, Annals of neurology.

[15]  Peter K Stys,et al.  Glutamate receptors on myelinated spinal cord axons: I. GluR6 kainate receptors , 2009, Annals of neurology.

[16]  B. Trapp,et al.  Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptors , 2009, Annals of neurology.

[17]  D. Turnbull,et al.  Review: Mitochondria and disease progression in multiple sclerosis , 2008, Neuropathology and applied neurobiology.

[18]  S. Waxman,et al.  Phenytoin protects central axons in experimental autoimmune encephalomyelitis , 2008, Journal of the Neurological Sciences.

[19]  Robin J. M. Franklin,et al.  Remyelination in the CNS: from biology to therapy , 2008, Nature Reviews Neuroscience.

[20]  D S Goodin,et al.  Assessment: The use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review) , 2008, Neurology.

[21]  Rohit Bakshi,et al.  MRI in multiple sclerosis: current status and future prospects , 2008, The Lancet Neurology.

[22]  Klaus-Armin Nave,et al.  Axon-glial signaling and the glial support of axon function. , 2008, Annual review of neuroscience.

[23]  B. Trapp,et al.  Multiple sclerosis: an immune or neurodegenerative disorder? , 2008, Annual review of neuroscience.

[24]  V. Gallo,et al.  Myelin repair strategies: a cellular view , 2008, Current opinion in neurology.

[25]  Christine Stadelmann,et al.  Cortical pathology in multiple sclerosis , 2008, Current opinion in neurology.

[26]  I. Ziabreva,et al.  Mitochondrial defects in acute multiple sclerosis lesions , 2008, Brain : a journal of neurology.

[27]  C. Stadelmann,et al.  From fish to man: understanding endogenous remyelination in central nervous system demyelinating diseases , 2008, Brain : a journal of neurology.

[28]  Kyle C. Kern,et al.  Regional hippocampal atrophy in multiple sclerosis. , 2008, Brain : a journal of neurology.

[29]  R. Rudick,et al.  Imaging correlates of decreased axonal Na+/K+ ATPase in chronic multiple sclerosis lesions , 2008, Annals of neurology.

[30]  R. Rudick,et al.  Activation of the ciliary neurotrophic factor (CNTF) signalling pathway in cortical neurons of multiple sclerosis patients. , 2007, Brain : a journal of neurology.

[31]  Elizabeth Fisher,et al.  Imaging correlates of axonal swelling in chronic multiple sclerosis brains , 2007, Annals of neurology.

[32]  S. Waxman,et al.  Sodium Channel Expression Within Chronic Multiple Sclerosis Plaques , 2007, Journal of neuropathology and experimental neurology.

[33]  Frederik Barkhof,et al.  Extensive Hippocampal Demyelination in Multiple Sclerosis , 2007, Journal of neuropathology and experimental neurology.

[34]  S. Waxman,et al.  Exacerbation of experimental autoimmune encephalomyelitis after withdrawal of phenytoin and carbamazepine , 2007, Annals of neurology.

[35]  Bruce D. Trapp,et al.  Pathogenesis of axonal and neuronal damage in multiple sclerosis , 2007, Neurology.

[36]  B. Trapp,et al.  Neurogenesis in the chronic lesions of multiple sclerosis , 2007, Brain : a journal of neurology.

[37]  Massimo Filippi,et al.  Functional MRI in Multiple Sclerosis , 2007, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[38]  Massimo Filippi,et al.  MR Spectroscopy in Multiple Sclerosis , 2007, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[39]  Massimo Filippi,et al.  Conventional MRI in Multiple Sclerosis , 2007, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[40]  Kenneth J. Smith,et al.  Sodium Channels and Multiple Sclerosis: Roles in Symptom Production, Damage and Therapy , 2007, Brain pathology.

[41]  Stephen G. Waxman,et al.  Axonal conduction and injury in multiple sclerosis: the role of sodium channels , 2006, Nature Reviews Neuroscience.

[42]  D. Bechtold,et al.  Axonal protection achieved in a model of multiple sclerosis using lamotrigine , 2006, Journal of Neurology.

[43]  Stephen G Waxman,et al.  Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE. , 2006, Brain : a journal of neurology.

[44]  S. Hauser,et al.  The Neurobiology of Multiple Sclerosis: Genes, Inflammation, and Neurodegeneration , 2006, Neuron.

[45]  P. Matthews,et al.  Neocortical neuronal, synaptic, and glial loss in multiple sclerosis , 2006, Neurology.

[46]  C. Mainero,et al.  Functional Brain Reorganization in Multiple Sclerosis: Evidence from fMRI Studies , 2006, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[47]  Ludwig Kappos,et al.  A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. , 2006, The New England journal of medicine.

[48]  R. Rudick,et al.  Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients , 2006, Annals of neurology.

[49]  B. Trapp,et al.  NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia , 2006, Nature.

[50]  D. Pham‐Dinh,et al.  Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat , 2006, Experimental Neurology.

[51]  D. Kirschner,et al.  Evolution of a neuroprotective function of central nervous system myelin , 2006, The Journal of cell biology.

[52]  M. Salter,et al.  NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury , 2005, Nature.

[53]  D. Attwell,et al.  NMDA receptors are expressed in oligodendrocytes and activated in ischaemia , 2005, Nature.

[54]  S. Reingold,et al.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” , 2005, Annals of neurology.

[55]  Roberto Mutani,et al.  Grey Matter Pathology in Multiple Sclerosis , 2005, Journal of neuropathology and experimental neurology.

[56]  Wolfgang Brück,et al.  The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage , 2005, Journal of Neurology.

[57]  Amanda L. Cox,et al.  Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis , 2005, European journal of immunology.

[58]  M. Filippi,et al.  Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenotypes , 2005, The Lancet Neurology.

[59]  G. Buckle,et al.  Functional Magnetic Resonance Imaging and Multiple Sclerosis: The Evidence for Neuronal Plasticity , 2005, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[60]  Ponnada A Narayana,et al.  Magnetic Resonance Spectroscopy in the Monitoring of Multiple Sclerosis , 2005, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[61]  K. Tyler,et al.  Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. , 2005, The New England journal of medicine.

[62]  Peter K. Stys,et al.  General mechanisms of axonal damage and its prevention , 2005, Journal of the Neurological Sciences.

[63]  Hans Lassmann,et al.  Cortical lesions and brain atrophy in MS , 2005, Journal of the Neurological Sciences.

[64]  D. Bechtold,et al.  Sodium-mediated axonal degeneration in inflammatory demyelinating disease , 2005, Journal of the Neurological Sciences.

[65]  S G Waxman,et al.  Multiple sclerosis as a neuronal disease. , 2005, Archives of neurology.

[66]  Daniel Pelletier,et al.  Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. , 2005, Brain : a journal of neurology.

[67]  S. Waxman.  Sodium channel blockers and axonal protection in neuroinflammatory disease. , 2004, Brain : a journal of neurology.

[68]  Vladimir Parpura,et al.  Mechanisms of glutamate release from astrocytes: gap junction “hemichannels”, purinergic receptors and exocytotic release , 2004, Neurochemistry International.

[69]  T. Vollmer,et al.  Randomized multicenter trial of natalizumab in acute MS relapses , 2004, Neurology.

[70]  G. Martino.  How the brain repairs itself: new therapeutic strategies in inflammatory and degenerative CNS disorders , 2004, The Lancet Neurology.

[71]  Nitin J. Karandikar,et al.  High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay. , 2004, Blood.

[72]  D. Bechtold,et al.  Axonal protection using flecainide in experimental autoimmune encephalomyelitis , 2004, Annals of neurology.

[73]  P. Stys.  White matter injury mechanisms. , 2004, Current molecular medicine.

[74]  K. Rajewsky,et al.  Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[75]  N. Stefano,et al.  Imaging neuronal and axonal degeneration in multiple sclerosis , 2003, Neurological Sciences.

[76]  A. Lo,et al.  Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo. , 2003, Journal of neurophysiology.

[77]  B D Trapp,et al.  Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration , 2003, Multiple sclerosis.

[78]  J. Geurts,et al.  Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis. , 2003, Brain : a journal of neurology.

[79]  J. Antel,et al.  Vulnerability of Human Neurons to T Cell-Mediated Cytotoxicity1 , 2003, The Journal of Immunology.

[80]  B. Trapp,et al.  Subpial Demyelination in the Cerebral Cortex of Multiple Sclerosis Patients , 2003, Journal of neuropathology and experimental neurology.

[81]  Noel R Rose,et al.  TH1-TH2: a Procrustean paradigm , 2003, Nature Immunology.

[82]  L. Turski,et al.  Multiple Sclerosis and Glutamate , 2003, Annals of the New York Academy of Sciences.

[83]  B. Ransom,et al.  Functional Hemichannels in Astrocytes: A Novel Mechanism of Glutamate Release , 2003, The Journal of Neuroscience.

[84]  P. M. Matthews,et al.  Evidence of early cortical atrophy in MS , 2003, Neurology.

[85]  Giuseppe Scotti,et al.  Evidence for axonal pathology and adaptive cortical reorganization in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis , 2003, NeuroImage.

[86]  K. Nave,et al.  Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination , 2003, Nature Genetics.

[87]  M Rovaris,et al.  Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. , 2003, Brain : a journal of neurology.

[88]  Hans Lassmann,et al.  Hypoxia-like tissue injury as a component of multiple sclerosis lesions , 2002, Journal of the Neurological Sciences.

[89]  P. Matthews,et al.  Thalamic neurodegeneration in multiple sclerosis , 2002, Annals of neurology.

[90]  A. Lo,et al.  Neuroprotection of axons with phenytoin in experimental allergic encephalomyelitis , 2002, Neuroreport.

[91]  P. Stys,et al.  Calpain-dependent neurofilament breakdown in anoxic and ischemic rat central axons , 2002, Neuroscience Letters.

[92]  Gian Domenico Iannetti,et al.  Cortical motor reorganization after a single clinical attack of multiple sclerosis. , 2002, Brain : a journal of neurology.

[93]  P. Rieckmann,et al.  Anti‐inflammatory strategies to prevent axonal injury in multiple sclerosis , 2002, Current opinion in neurology.

[94]  H. Bading,et al.  Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways , 2002, Nature Neuroscience.

[95]  R. Gold,et al.  Association of a null mutation in the CNTF gene with early onset of multiple sclerosis. , 2002, Archives of neurology.

[96]  Arturo Alvarez-Buylla,et al.  Neurogenesis in Adult Subventricular Zone , 2002, The Journal of Neuroscience.

[97]  H. Przuntek,et al.  A null mutation within the ciliary neurotrophic factor (CNTF)-gene: implications for susceptibility and disease severity in patients with multiple sclerosis , 2002, Genes and Immunity.

[98]  B. Trapp,et al.  Axon Loss in the Spinal Cord Determines Permanent Neurological Disability in an Animal Model of Multiple Sclerosis , 2002, Journal of neuropathology and experimental neurology.

[99]  M. Luskin,et al.  Neurogenesis in the Subventricular Zone and Rostral Migratory Stream of the Neonatal and Adult Primate Forebrain , 2001, Experimental Neurology.

[100]  R. Kinkel,et al.  Axonal loss in normal-appearing white matter in a patient with acute MS , 2001, Neurology.

[101]  J. Goverman,et al.  A Pathogenic Role for Myelin-Specific Cd8+ T Cells in a Model for Multiple Sclerosis , 2001, The Journal of experimental medicine.

[102]  H. Neumann,et al.  Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes. , 2001, The American journal of pathology.

[103]  B. Trapp,et al.  Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.

[104]  P M Matthews,et al.  Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. , 2001, Brain : a journal of neurology.

[105]  Lawrence Steinman,et al.  Multiple sclerosis: a two-stage disease , 2001, Nature Immunology.

[106]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[107]  M. Goldberg,et al.  AMPA/Kainate Receptor Activation Mediates Hypoxic Oligodendrocyte Death and Axonal Injury in Cerebral White Matter , 2001, The Journal of Neuroscience.

[108]  H. Lassmann,et al.  Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis. , 2001, Brain : a journal of neurology.

[109]  C. Brosnan,et al.  Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. , 2001, The American journal of pathology.

[110]  P. Rakić,et al.  The generation, migration, and differentiation of olfactory neurons in the adult primate brain , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[111]  A. Pérez-Samartín,et al.  The link between excitotoxic oligodendroglial death and demyelinating diseases , 2001, Trends in Neurosciences.

[112]  J. Prineas,et al.  Pathology of Multiple Sclerosis , 2001 .

[113]  R. Rudick,et al.  Neurological disability correlates with spinal cord axonal loss and reduced N‐acetyl aspartate in chronic multiple sclerosis patients , 2000, Annals of neurology.

[114]  G Cutter,et al.  Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients , 2000 .

[115]  Adelbert Ames,et al.  CNS energy metabolism as related to function , 2000, Brain Research Reviews.

[116]  P M Matthews,et al.  Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis. , 2000, Brain : a journal of neurology.

[117]  Hans Lassmann,et al.  Clonal Expansions of Cd8+ T Cells Dominate the T Cell Infiltrate in Active Multiple Sclerosis Lesions as Shown by Micromanipulation and Single Cell Polymerase Chain Reaction , 2000, The Journal of experimental medicine.

[118]  R Kikinis,et al.  Changes in activated T cells in the blood correlate with disease activity in multiple sclerosis. , 2000, Archives of neurology.

[119]  H. Lassmann,et al.  Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. , 2000, The American journal of pathology.

[120]  V. Perry,et al.  [The evidence for primary axonal loss in multiple sclerosis]. , 2000, Revista de neurologia.

[121]  J. Parisi,et al.  Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.

[122]  W. Brück,et al.  Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. , 2000, Brain : a journal of neurology.

[123]  P. Matthews,et al.  Proton MR spectroscopy to assess axonal damage in multiple sclerosis and other white matter disorders. , 2000, Journal of neurovirology.

[124]  M. Palkovits,et al.  Axonal changes in chronic demyelinated cervical spinal cord plaques. , 2000, Brain : a journal of neurology.

[125]  Shuxin Li,et al.  Mechanisms of Ionotropic Glutamate Receptor-Mediated Excitotoxicity in Isolated Spinal Cord White Matter , 2000, The Journal of Neuroscience.

[126]  Ganter,et al.  Spinal cord axonal loss in multiple sclerosis: a post‐mortem study , 1999, Neuropathology and applied neurobiology.

[127]  V. Stevenson,et al.  Magnetic resonance imaging in the monitoring of disease progression in multiple sclerosis , 1999, Multiple sclerosis.

[128]  J. Noseworthy.  Progress in determining the causes and treatment of multiple sclerosis , 1999, Nature.

[129]  B D Trapp,et al.  Axonal pathology in multiple sclerosis: relationship to neurologic disability. , 1999, Current opinion in neurology.

[130]  J. Baskerville,et al.  The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. , 1999, Brain : a journal of neurology.

[131]  R. Rudick,et al.  Neurodegeneration in Multiple Sclerosis: Relationship to Neurological Disability , 1999 .

[132]  F. Gage,et al.  Neurogenesis in the adult human hippocampus , 1998, Nature Medicine.

[133]  Nicholas W. Plummer,et al.  Functional Analysis of the Mouse Scn8a Sodium Channel , 1998, The Journal of Neuroscience.

[134]  K. Nave,et al.  Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. , 1998, Science.

[135]  Virginia M. Y. Lee,et al.  Myelin-Associated Glycoprotein Is a Myelin Signal that Modulates the Caliber of Myelinated Axons , 1998, The Journal of Neuroscience.

[136]  R. Rudick,et al.  Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.

[137]  K. Nave.  Myelin-specific genes and their mutations in the mouse , 1997 .

[138]  W. Richardson,et al.  Glial cell development : basic principles and clinical relevance , 1997 .

[139]  R. Franklin,et al.  Local recruitment of remyelinating cells in the repair of demyelination in the central nervous system , 1997, Journal of neuroscience research.

[140]  R. Hohlfeld,et al.  Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives. , 1997, Brain : a journal of neurology.

[141]  E. Lehning,et al.  Intracellular Concentrations of Major Ions in Rat Myelinated Axons and Glia: Calculations Based on Electron Probe X‐Ray Microanalyses , 1997, Journal of neurochemistry.

[142]  C. Lucchinetti,et al.  Remyelination in multiple sclerosis , 1997, Multiple sclerosis.

[143]  V. Perry,et al.  Axonal damage in acute multiple sclerosis lesions. , 1997, Brain : a journal of neurology.

[144]  P. Matthews,et al.  Imaging of axonal damage in multiple sclerosis: Spatial distribution of magnetic resonance imaging lesions , 1997, Annals of neurology.

[145]  K. Nave,et al.  Assembly of CNS Myelin in the Absence of Proteolipid Protein , 1997, Neuron.

[146]  G. Mckhann,et al.  Acute motor axonal neuropathy: An antibody‐mediated attack on axolemma , 1996, Annals of neurology.

[147]  R. Nixon,et al.  Oligodendroglia Regulate the Regional Expansion of Axon Caliber and Local Accumulation of Neurofilaments during Development Independently of Myelin Formation , 1996, The Journal of Neuroscience.

[148]  S. Cook,et al.  Handbook of Multiple Sclerosis , 1996 .

[149]  P M Matthews,et al.  Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy. , 1996, Brain : a journal of neurology.

[150]  T. Palmer,et al.  Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[151]  M. Dubois‐Dalcq.  Regeneration of oligodendrocytes and myelin , 1995, Trends in Neurosciences.

[152]  R. Paul,et al.  Identifying multiple sclerosis patients with mild or global cognitive impairment using the Screening Examination for Cognitive Impairment (SEFCI) , 1995, Neurology.

[153]  D. Hanley,et al.  Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains , 1994, Annals of neurology.

[154]  S. Lipton,et al.  Excitatory amino acids as a final common pathway for neurologic disorders. , 1994, The New England journal of medicine.

[155]  Maria B. Luskin,et al.  Restricted proliferation and migration of postnatally generated neurons derived from the forebrain subventricular zone , 1993, Neuron.

[156]  Peter K. Stys,et al.  Ultrastructural concomitants of anoxic injury and early post-anoxic recovery in rat optic nerve , 1992, Brain Research.

[157]  Stephen M. Rao,et al.  Cognitive dysfunction in multiple sclerosis. , 1991, Neurology.

[158]  B Bass,et al.  The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. , 1989, Brain : a journal of neurology.

[159]  S G Waxman,et al.  Membranes, myelin, and the pathophysiology of multiple sclerosis. , 1982, The New England journal of medicine.

[160]  J. Hinds,et al.  Neurogenesis in the adult rat: electron microscopic analysis of light radioautographs. , 1977, Science.

[161]  J. Altman,et al.  Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats , 1965, The Journal of comparative neurology.

[162]  B. Brownell,et al.  The distribution of plaques in the cerebrum in multiple sclerosis , 1962, Journal of neurology, neurosurgery, and psychiatry.

[163]  H. Hartung,et al.  Disease-Modifying Agents for Multiple Sclerosis , 2012, Drugs.

[164]  D. Arnold,et al.  The role of MRS and fMRI in multiple sclerosis. , 2006, Advances in neurology.

[165]  B. Trapp,et al.  12 – Axonal Degeneration in Multiple Sclerosis: The Histopathological Evidence , 2005 .

[166]  W. Brück,et al.  BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells? , 2002, Brain : a journal of neurology.

[167]  P M Matthews,et al.  Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. , 2001, Archives of neurology.

[168]  D. Pitt,et al.  Glutamate excitotoxicity in a model of multiple sclerosis , 2000, Nature Medicine.

[169]  L. Turski,et al.  Autoimmune encephalomyelitis ameliorated by AMPA antagonists , 2000, Nature Medicine.

[170]  F. Barkhof,et al.  Cortical lesions in multiple sclerosis. , 1999, Brain : a journal of neurology.

[171]  G. Mckhann,et al.  Human autoimmune neuropathies. , 1998, Annual review of neuroscience.

[172]  K. Jessen.  Glial cell development , 1996 .

[173]  B. Weinshenker,et al.  Natural history of multiple sclerosis , 1994, Annals of neurology.